Matthew Sorenson, PhD, APRN, ANP-C, FAAN

Representative Publications

Peer-Reviewed Publications (*Student mentee)

• Martinez-Torteya, C., Figge, C., Gilchrist, M. A., Muzik, M., King, A., & Sorenson, M. (2018). Prenatal Intimate Partner Violence Exposure Predicts Infant Biobehavioral Regulation: Moderation by the brain- derived neurotrophic factor (BDNF) Gene. Development and Psychopathology, 30(03), 1009-1021. DOI:
  10.1017/S0954579418000329
• Jason, LA., Ohanian, D., Brown, A., Sunnquist, M., McManimen, S., Klebek, L., Fox, P., & Sorenson, M. (2017). Differentiating Multiple Sclerosis from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. Insights in Biomedicine, 2(2). DOI: 10.21767/2572-5610.100011
• Sorenson, M., Furst, J., Mathews, H., & Jason, L. (2017, Online ahead of Print). Dysregulation of cytokine pathways in Chronic Fatigue Syndrome and Multiple Sclerosis. Fatigue, Biomedicine, Health & Behavior. DOI: 10.1080/21641846.2017.1335237
• Talbott, C., Watson, L., Tariman, J., & Sorenson, M. (2016). Clinical Chatter: Every Nurse Informed. Journal of Clinical Nursing, 26(9-10), 1301-312. DOI: 10.1111/jocn.13620
• Newland, P., Starkweather, A., & Sorenson, M. (2016). Central Fatigue in Multiple Sclerosis - A Review of the Literature. Journal of Spinal Cord Medicine, 5, 1-14. DOI:10.1080/10790268.2016.1168587
• Newland, P., Starkweather, A., & Sorenson, M. (2016). Central Fatigue in Multiple Sclerosis - A Review of the Literature. Journal of Spinal Cord Medicine, 5, 1-14. DOI:10.1080/10790268.2016.1168587
• Kubow, S., Sorenson, M., Alkazemi, D., Roberts II, L.J., Adamski, K.N., & Jason, L.A. (2015). Novel associations of F2-Isoprostanes, F3- Isoprostanes and Isofurans in older adults with chronic fatigue syndrome: An exploratory study. Clinical Research: Open Access. DOI: http://dx.doi.org/10.16966/clroa.103
• Sorenson, M., Jason, L., Peterson, J., Herrington, J., & Mathews, H. (2014). Brain Derived Neurotrophic Factor is Decreased in Chronic Fatigue Syndrome and Multiple Sclerosis. Journal of Neurology and Neurophysiology, S12:013, http://dx.doi.org/10.4172/2155-9562.S12- 013
• Sorenson, M., and Jason, L. (2013). Dysregulation of the HPA Axis in Chronic Fatigue Syndrome. Advances in Neuroimmune Biology, 4(4), DOI: 10.3233/NIB-130071
• Rizio, N., Tran, C., & Sorenson, M. (2012). Invited Review: Efficacy and Satisfaction of Oral Pharmacotherapies in the Treatment of Erectile Dysfunction in Men with Spinal Cord Injuries: A Literature Review. Journal of Spinal Cord Medicine, 35(4), 219-228.
• Sorenson, M., Jason, L., Lerch, A., Porter, N., Peterson, J., Herrington, J., & Mathews, H. (2012). The production of Interluekin-8 is increased in the Peripheral Blood Mononuclear Cells of Patients with Fatigue. Neuroscience and Medicine, 3(1), 47-53.
• Jason, LA., Sorenson, M., Roberts, J., Sebally, J. K., Alkazemi, D., & Kubow, S. (2011). Increased HDAC in association with decreased plasma cortisol in older adults with chronic fatigue syndrome. Brain, Behavior and Immunity, 25, 1544-1547
• Jason, L.A., Sorenson, M., Porter, N., & Belkairous, N. (2011). An etiological model for Myalgic Encephalomyelitis/chronic fatigue syndrome. Neuroscience & Medicine, 2, 14-27.
• Gwin, J., Drews, N., Syed, A., Stanschror, J., Sorenson, M., & Rajah, T. (2011). Effect of Genistein on p90RSK Phosphorylation and Cell Proliferation in T47D Breast Cancer Cells. Anticancer Research, 31(1), 209-214.
• Porter, N., Lerch, A., Jason, L.A., Sorenson, M., & Fletcher, M.A. (2010). A comparison of immune functionality in viral versus non-viral CFS subtypes. Journal of Behavioral and Neuroscience Research, 8(2), 1-8.
• Jason, L.A., Sorenson, M., Porter, N., Brown, M., Lerch, A., Van der Eb, C., & Mikovits J. (2010). Possible genetic dysregulation in pediatric CFS. Psychology, 1, 247-251.
• Sorenson, M. (2010). Immunosenescence: An Unappreciated Risk. MedSurg Matters, 1, 6-8.
• Jason, L.A., Porter, N., Herrington, J., & Sorenson, M., & Kubow, S. (2009).Kindling and oxidative stress as contributors to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Journal of Behavioral and Neuroscience Research, 7, 1-17.
• Torres-Harding, S., Sorenson, M., Jason, L.A., Maher, K., Fletcher, M.A., Reynolds, N., & Brown, M. (2008). The associations between basal salivary cortisol levels and illness symptomatology in chronic fatigue syndrome. Journal of Applied Biobehavioral Research, 13(3), 157-180.
• Torres-Harding, S., Sorenson, M., Jason, L.A., Maher, K., & Fletcher, M.A. (2008). Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS). Bulletin of IACFS/ME, 16(3), 19-33.
• Jason, L.A., Torres-Harding, S., Brown, M., Sorenson, M., Donalek, J., Corradi, K., Maher, K., & Fletcher, M.A. (2008). Predictors of change following participation in non-pharmacologic interventions for CFS. Tropical Medicine and Health, 36(1), 23-32.
• Jason, L.A., Torres-Harding, S., Maher, K., Reynolds, N., Brown, M., Sorenson, M., Fletcher, M.A., & Lu, T. (2007). Normal versus abnormal cortisol predict treatment outcomes in a CFS non-pharmacologic clinical trial. Journal of Chronic Fatigue Syndrome, 14, 39-59.